The Multiple Sclerosis Resource Centre
Saturday, 31 July 2010The MS 24 Hour Telephone Counselling Service 0800 783 0518 (then press 1)
MSRC Logo
 
Search this site
Information
Home
Site Map
About MS
  Latest MS News
  Types of Multiple Sclerosis
  Myelin
  Symptoms
  Multiple Sclerosis Diagnosis
  Paediatric Multiple Sclerosis
  Causes of MS
  Multiple Sclerosis Treatments
    Drug Treatments
      Disease Modifying Drugs
      Low Dose Naltrexone
        First European LDN Conference Report
        Prescribing Low Dose Naltrexone – A Guide
        Dr. Kamau B. Kokayi Interviews Dr. Bihari
        The First Low Dose Naltrexone Conference
        The Second Low Dose Naltrexone Conference
        2010 LDN Conference Report
      Corticosteroids
      Amantadine
      Intravenous Immunoglobulin
      Baclofen (Lioresal)
    Complementary Therapies
    Combating Multiple Sclerosis Fatigue
    Counselling
    Exercise and Physiotherapy
    MS Health Tips
    Dr Bob Lawrence's Advice
    Susie Cornell's Clinic
    Diet and MS
    Supplements
  Health Consequences of MS
  The Geography Of Multiple Sclerosis
  MS Nurses
  Associated Illnesses
  Research / Trials
  Mobility Issues
  Financial Impact
  Communication
MSRC Services
Get Involved
MS Research News
MSRC Groups
Useful Resources
The Best Bet Diet Group
Advertising
Current Vacancies At MSRC
MSRC Guest Book
 
Interactive
Join Us
Member Log In
My MSRC
Contact MSRC
Site Map
 

Investor in People
Investor in People

content management system by:
Content Management and Website architecture by datapartners.co.uk
You are here : Home : About MS : Multiple Sclerosis Treatments : Drug Treatments : Low Dose Naltrexone
Low Dose Naltrexone Print this page
 
Share |

Low Dose NaltrexoneThis is a drug quite widely used in the United States though not readily available on prescription here in the UK, some doctors and/neurologists will prescribe.

It is still considered experimental by some but is being used my many for their MS.

The drug, which is also reported to help with the effects of cancer, Aids and rheumatoid arthritis, works by creating a surge in endorphins to restore patients’ immune systems.

Many people are reporting improvements in their MS symptoms, such as less fatigue and an improved bladder, as well as a stabilisation in their condition.

Further Information

  • LDN Information Pack 
  • LDN Treatment Page
  • Prescribing Low Dose Naltrexone – A Guide 
  • Low Dose Naltrexone - Latest News
  • 2010 LDN Conference 
  • First European LDN Conference Report
  • Dr. Kamau B. Kokayi Interviews Dr. Bihari
  • The First Annual Low Dose Naltrexone Conference
  • The Second Annual Low Dose Naltrexone Conference 


    LDN Aware Logo

    This website is the worldwide gateway to Low Dose Naltrexone information, resources and events.  LDN Aware is a volunteer group devoted entirely to spreading knowledge and raising public awareness about LDN as a treatment for auto-immune disease, cancer and HIV/AIDS.

    Website: http://www.ldnaware.org/

    © Multiple Sclerosis Resource Centre 



  • Related Items
    2010 LDN Conference Report
    Dr. Kamau B. Kokayi Interviews Dr. Bihari
    First European LDN Conference Report
    Prescribing Low Dose Naltrexone – A Guide
    The First Low Dose Naltrexone Conference
    The Second Low Dose Naltrexone Conference
    Amantadine
    Baclofen (Lioresal)
    Corticosteroids
    Disease Modifying Drugs
    Intravenous Immunoglobulin


    Did you find this information useful? Would you like to comment on this page? Let us know what you think! We welcome all comments and feedback on any aspect of our website - please click here to contact us.
    © 2002 - 2010 MSRC  |  Registered Charity No 1033731  | FREEPHONE 0800 783 0518 |  Back to Top